Shares of Biocon rallied 4% on Monday, 2 December, after the company announced that its subsidiary, Biocon Biologics, had received approval from the US Food...
Biocon shares fell 2% to Rs 258.50 at 9:27 am on Monday after the company acknowledged six US Food and Drug Administration (USFDA) observations. The...
Biocon Biologics Ltd said on Tuesday its subsidiary had secured a three-year contract from the Malaysian government worth $90 million (approximately Rs 688 crore) to...
Biocon Ltd NSE :BIOCON BSE :532523 Sector : Pharmaceuticals About Company: Biocon is engaged in the business of manufacture of biotechnology products and research services. Has one of the...
Biocon Ltd NSE :BIOCON BSE :532523 Sector : Pharmaceuticals About Company: Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India founded by Kiran Mazumdar-Shaw. The...
Biocon Biologics Ltd has received the European Medicines Agency’s certification for good manufacturing practices for its biologics drug substance facility at Bengaluru, the company’s parent...